We studied the molecular mechanisms mediating these phenotypes and discovered that HDAC3 KD in BMSC causes increased secretion of soluble glycoprotein 130 (sgp130), which results in dysregulation of IL-6 trans-signaling, a well-established pro-survival pathway in MM. This evidence concerns the gene IL6 and Miyoshi myopathy.